Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

5-alpha reductase inhibitors like finasteride and dutasteride are effective for treating enlarged prostate and male pattern hair loss.

Early balding may be a sign of future prostate problems.

Marijuana use is linked to higher chances of needing treatment for urinary symptoms in men over 40.

Finasteride users have a very low risk of mental health issues, but those with hair loss may have slightly higher anxiety and depression.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Antiandrogens may help treat conditions like excessive hair growth, prostate tumors, male baldness, and acne by blocking male hormone effects.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Both drugs lower DHT levels, with GI198745 being more effective.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

The methods accurately measure finasteride and tadalafil in Entadfi™ capsules for quality control.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.

Finasteride use is strongly linked to sexual dysfunction, especially in young men treating hair loss.

Young patients using finasteride may have higher risks of anxiety, depression, and suicidal thoughts.

AT-Grow, a natural product, might help with a common type of hair loss by reducing DHT levels.

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

Methylation in specific gene region causes finasteride resistance in some BPH patients.

Hair loss can be an early sign of prostate enlargement.

Ganoderma lucidum, a type of mushroom, may help treat enlarged prostate by blocking testosterone conversion.

Chewing betel nut may increase the risk of type 2 diabetes, and saw palmetto can improve urinary symptoms in BPH with fewer side effects but may cause bleeding and allergic reactions.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.